FDA Clarifies Approval Pathways for Applications in New Draft Guidance

Generic Line
A A
In a new draft guidance, the FDA describes which abbreviated approval pathways are available for ANDAs and 505(b)(2) applications.

To View This Article:

Login

Subscribe To Generic Line